This is a StreetInsider.com Premium Only Page

Aytu BioScience (AYTU) –

Apr 3, 2024 09:00 AM Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024

Apr 3, 2024 07:00 AM Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now

Apr 2, 2024 04:44 PM Form 4 AYTU BIOPHARMA, INC For: Mar 31 Filed by: PYSZCZYMUKA GREG

Feb 14, 2024 04:23 PM Aytu BioScience (AYTU) Misses Q2 EPS by 4c

Feb 14, 2024 04:13 PM Form 8-K AYTU BIOPHARMA, INC For: Feb 14

Feb 14, 2024 04:08 PM Form 10-Q AYTU BIOPHARMA, INC For: Dec 31

Feb 14, 2024 04:05 PM Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter

Feb 13, 2024 04:26 PM Form SC 13G/A AYTU BIOPHARMA, INC Filed by: Stonepine Capital Management, LLC

Feb 7, 2024 04:15 PM Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024

Jan 23, 2024 09:00 AM Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Jan 2, 2024 04:38 PM Form 4 AYTU BIOPHARMA, INC For: Dec 31 Filed by: PYSZCZYMUKA GREG

Dec 6, 2023 07:00 AM Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now

Nov 30, 2023 08:00 AM Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023

Nov 17, 2023 04:11 PM Form 8-K AYTU BIOPHARMA, INC For: Nov 13

Nov 14, 2023 07:50 PM Form 8-K AYTU BIOPHARMA, INC For: Nov 14

Nov 14, 2023 04:43 PM Form 10-Q AYTU BIOPHARMA, INC For: Sep 30

Nov 14, 2023 04:18 PM Aytu BioScience (AYTU) Reports Q1 Revenue of $22.1M, Net Loss of $8.1M

Nov 14, 2023 04:05 PM Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Nov 8, 2023 08:30 AM Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year

Nov 7, 2023 04:15 PM Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023

Oct 26, 2023 08:06 AM Form 8-K AYTU BIOPHARMA, INC For: Oct 25

Oct 26, 2023 08:05 AM Aytu BioScience (AYTU) Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

Oct 26, 2023 08:00 AM Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

Oct 12, 2023 02:52 PM Form 10-K AYTU BIOPHARMA, INC For: Jun 30

Oct 9, 2023 04:15 PM Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023

Oct 6, 2023 04:33 PM Aytu BioScience (AYTU) Announces COO Departure

Oct 6, 2023 04:31 PM Form 8-K AYTU BIOPHARMA, INC For: Oct 03

Oct 3, 2023 04:37 PM Form 4 AYTU BIOPHARMA, INC For: Sep 30 Filed by: PYSZCZYMUKA GREG

Sep 29, 2023 04:16 PM Form NT 10-K AYTU BIOPHARMA, INC For: Jun 30

Sep 27, 2023 04:22 PM Aytu BioScience (AYTU) Reports Q3

Sep 27, 2023 04:20 PM Form 8-K AYTU BIOPHARMA, INC For: Sep 27

Sep 26, 2023 08:27 PM Aytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023

Sep 21, 2023 08:25 PM Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023

Sep 13, 2023 08:00 AM Aytu BioPharma to Present at LD Micro Main Event XVI Conference

Aug 18, 2023 06:27 PM Form 4 AYTU BIOPHARMA, INC For: Aug 16 Filed by: JAIN ABHINAV

Aug 15, 2023 08:57 PM Form 4 AYTU BIOPHARMA, INC For: Aug 11 Filed by: Disbrow Jarrett

Aug 15, 2023 07:49 PM Form 4 AYTU BIOPHARMA, INC For: Aug 11 Filed by: JAIN ABHINAV

Aug 15, 2023 07:45 PM Form 4 AYTU BIOPHARMA, INC For: Aug 11 Filed by: LIU VIVIAN H

Aug 15, 2023 07:40 PM Form 4 AYTU BIOPHARMA, INC For: Aug 11 Filed by: Donofrio John Jr.

Aug 15, 2023 07:38 PM Form 4 AYTU BIOPHARMA, INC For: Aug 11 Filed by: DOCKERY CARL

Aug 15, 2023 07:35 PM Form 4 AYTU BIOPHARMA, INC For: Aug 11 Filed by: Disbrow Joshua R.

Aug 15, 2023 07:30 PM Form 4 AYTU BIOPHARMA, INC For: Aug 11 Filed by: BROOKE CHRISTOPHER

Aug 15, 2023 07:29 PM Form 4 AYTU BIOPHARMA, INC For: Aug 11 Filed by: Oki Mark K

Aug 15, 2023 07:21 PM Form 4 AYTU BIOPHARMA, INC For: Aug 11 Filed by: PYSZCZYMUKA GREG

Aug 15, 2023 04:11 PM Form 8-K AYTU BIOPHARMA, INC For: Aug 11

Aug 8, 2023 09:15 AM Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline

Aug 8, 2023 07:24 AM Maxim Group Starts Aytu Biosciences (AYTU) at Buy

Jul 31, 2023 08:05 AM Form 8-K AYTU BIOPHARMA, INC For: Jul 31

Jul 31, 2023 08:01 AM Aytu BioScience (AYTU) Enters Agreement with Medomie Pharma to Commercialize Adzenys XR-ODT and Cotempla XR-ODT in Israel and Palestine

Jul 31, 2023 08:00 AM Aytu BioPharma Announces Exclusive Agreement with Medomie Pharma Ltd. to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Israel and the Palestinian Authority